Thermo Fisher Scientific Q2 FY26: where the revenue came from and where it went
The whole income statement of Thermo Fisher Scientific for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Mar 29 – Jun 27, 2026
- Reported
- Jul 31, 2026
Revenue$11.99B
+10% year over year
Gross profit$4.75B
40% margin
Operating profit$2.09B
17% margin
Net profit$1.74B
14% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 11.99 | 100% | +10% |
| Services | 5.17 | 43% | +12% |
| Product consumables | 5.07 | 42% | |
| Product instruments | 1.75 | 15% | |
| Cost of revenue | −7.24 | 60% | |
| Gross profit | 4.75 | 40% margin | +0pp |
| R&D | −0.36 | 3% | +0pp |
| SG&A | −2.30 | 19% | +0pp |
| Operating profit | 2.09 | 17% margin | +1pp |
| Interest & other costs | −0.18 | ||
| Tax | −0.17 | ||
| Net profit | 1.74 | 14% margin |
214 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest